tradingkey.logo

Bio Rad Laboratories Inc

BIOb
View Detailed Chart
300.500USD
-4.970-1.63%
Close 12/19, 16:00ETQuotes delayed by 15 min
8.11BMarket Cap
LossP/E TTM

Bio Rad Laboratories Inc

300.500
-4.970-1.63%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.63%

5 Days

-3.19%

1 Month

-1.20%

6 Months

0.00%

Year to Date

0.00%

1 Year

0.00%

View Detailed Chart

Key Insights

Bio Rad Laboratories Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 149/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very low.Despite an average stock market performance over the past month, the company shows strong fundamentals.

Bio Rad Laboratories Inc's Score

Industry at a Glance

Industry Ranking
149 / 208
Overall Ranking
402 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Bio Rad Laboratories Inc Highlights

StrengthsRisks
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Fairly Valued
The company’s latest PE is 0.00, at a medium 3-year percentile range.

Bio Rad Laboratories Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Bio Rad Laboratories Inc Info

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Ticker SymbolBIOb
CompanyBio Rad Laboratories Inc
CEOSchwartz (Norman D)
Websitehttps://www.bio-rad.com/

FAQs

What is the current price of Bio Rad Laboratories Inc (BIOb)?

The current price of Bio Rad Laboratories Inc (BIOb) is 300.500.

What is the symbol of Bio Rad Laboratories Inc?

The ticker symbol of Bio Rad Laboratories Inc is BIOb.

What is the 52-week high of Bio Rad Laboratories Inc?

The 52-week high of Bio Rad Laboratories Inc is 359.220.

What is the 52-week low of Bio Rad Laboratories Inc?

The 52-week low of Bio Rad Laboratories Inc is 225.290.

What is the market capitalization of Bio Rad Laboratories Inc?

The market capitalization of Bio Rad Laboratories Inc is 8.11B.

What is the net income of Bio Rad Laboratories Inc?

The net income of Bio Rad Laboratories Inc is -1.84B.

Is Bio Rad Laboratories Inc (BIOb) currently rated as Buy, Hold, or Sell?

According to analysts, Bio Rad Laboratories Inc (BIOb) has an overall rating of --, with a price target of --.

What is the Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIOb)?

The Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIOb) is -24.014.
KeyAI